does glp 1 damage kidneys Glucagon-Like Peptide-1 Receptor Agonist Use in People Living with Type 2 Diabetes Mellitus and Chronic Kidney Disease: A Narrative Review of the Key Evidence with Practical Considerations | Diabetes Therapy GLP-1 Receptor Agonists and Kidney

Quick Answer: GLP-1 probiotics lack robust clinical evidence for meaningful weight loss and are not FDA-approved alternatives to prescription medications like semaglutide or tirzepatide

We believe patients should know where their medication comes from and how quality is verified

As weight stabilizes, taste and smell tend to return to a more normal state, he said

Solutions like MeAgain centralize injections, symptom entries, hydration, and protein logs, giving clinicians a clean timeline that reduces time spent reconciling histories and makes lab interpretation faster and less burdensome

Patients on prolonged orforglipron therapy should have periodic DEXA scans monitoring both body composition and bone density

Sharing a recently published set of practical recommendations by Harvard scientists for patients using highly effective GLP-1 medications